Evidence map›Paper›PMID 42135521›Full record

ArticleNature chemical biology2026

Genetically targeted mTORC1 inhibitor reveals transcriptional control by nuclear mTORC1.

Yanghao Zhong, Ayse Z Sahan, Zhengyao Shao, Qian-Yi Zhang, Xin Zhou, Jack G Haggett, Keiichi Koshizuka, Samuel A Myers, J Silvio Gutkind, Jin Zhang

Abstract read
In one paragraph

Article in Nature chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yanghao Zhong *Department of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
Ayse Z Sahan *Department of Pharmacology, University of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-4661-035X
Zhengyao ShaoDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-2965-8335
Qian-Yi ZhangDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
Xin ZhouDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0009-0008-2426-2247
Jack G HaggettLaboratory for Immunochemical Circuits, La Jolla Institute for Immunology, La Jolla, CA, USA.
Keiichi KoshizukaDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
Samuel A MyersDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
J Silvio GutkindDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
Jin ZhangDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA. jzhang32@health.ucsd.edu.ORCID http://orcid.org/0000-0001-7145-7823

Funding

GRADUATE TRAINING IN CELLULAR &MOLECULAR PHARMACOLOGYT32GM007752 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, HANDEL, TRACY M · 1985 to 2023
$13.5M
Live-cell Activity Architecture in CancerR35CA197622 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jin Zhang · 2015 to 2026
$11.2M
Signal Transduction by PI3K/mTORR01DE030497 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GUTKIND, JORGE SILVIO, ZHANG, JIN · 2021 to 2025
$2.4M
Spatial regulation of mechanistic target of rapamycin complex 1 (mTORC1) and its role in oral squamous cell carcinomaF31DE032886 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SAHAN, AYSE ZISAN · 2023 to 2024
$85k
NCI NIH HHS R35 CA197622NIDCR NIH HHS F31 DE032886NIDCR NIH HHS R01 DE030497NIGMS NIH HHS T32 GM007752U.S. Department of Health & Human Services | National Institutes of Health (NIH) CA197622U.S. Department of Health & Human Services | National Institutes of Health (NIH) DE030497U.S. Department of Health & Human Services | National Institutes of Health (NIH) DE032886U.S. Department of Health & Human Services | National Institutes of Health (NIH) GM007752
6 · The paper itself

Abstract

Mechanistic target of rapamycin complex 1 (mTORC1) is a nutrient sensor that integrates diverse inputs to regulate protein translation and cell growth. While mTORC1 is activated on the lysosome in the classical model, it has become increasingly clear that this multifaceted signaling complex is active at various subcellular locations, such as the nucleus. However, what specific functions mTORC1 serves at these locations and how its signaling is compartmentalized are unclear. To interrogate subcellular pools of mTORC1, we developed TerminaTOR, a genetically encodable inhibitor of mTORC1 that can be targeted to specific subcellular locations. When TerminaTOR is directed to the lysosome, it inhibits canonical lysosomal mTORC1 and induces autophagy. Furthermore, TerminaTOR targeted to the nucleus specifically inhibits nuclear mTORC1, uncovering noncanonical roles of nuclear mTORC1 in regulating the transcription of CCAAT motif-containing genes. Thus, mTORC1 exhibits functional spatial compartmentalization and TerminaTOR serves as a powerful tool for unraveling spatially regulated functions of mTORC1 across different scales.

Identifiers

PMID42135521
PMCPMC13401988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.